Optimizing Risk Assessment Through cfDNA in Pancreatic Neuroendocrine Tumors for Clinical Evaluation: a Retrospective Study

​ Conditions: Pancreatic Neuroendocrine Tumor

Interventions: Other: cfDNA molecular profiling

Sponsors: Massimo Falconi

Active, not recruiting Conditions: Pancreatic Neuroendocrine Tumor
Interventions: Other: cfDNA molecular profiling
Sponsors: Massimo Falconi
Active, not recruiting